Clinical trial Recruiting at 1 site Interventional Ages 45 to 75

Effects of P24 on post-meal amino acids in healthy adults

Official title: Effects of an Acid-Active Protease (P24) on Postprandial Aminoacidemia Following a Standardized Mixed-Protein Burger Meal in Healthy Adults

Run by Amplifye · NCT07479173 · Data updated 2026-11-12

This study tests whether the acid-active protease P24 changes amino acid levels after a mixed-protein meal in healthy adults.

Quick facts

Study typeInterventional
Ages45 Years to 75 Years
SexAll
Enrollment30 (estimated)
SponsorAmplifye
Industry-sponsored
Locations1 site (Davis, California)
StatusRecruiting
StartedSeptember 5, 2026
Main results expectedMarch 31, 2027
Study endsDecember 15, 2027
Registry record updatedSeptember 9, 2026
Trial IDNCT07479173 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Healthy adults aged 45–75 with BMI 18.5–35 kg/m2 who can consume the test meal and comply with study procedures.

Probably not a fit

Individuals with GI disorders, diabetes, certain medications, high blood pressure, pregnancy, smoking, or severe dietary restrictions may not benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, double-blind, placebo-controlled crossover trial in healthy adults to see if the protease enzyme supplement P24 alters postprandial amino acid availability after a standardized mixed-protein meal. Participants receive P24 in one morning visit and placebo in a separate visit about a week apart, serving as their own controls. Primary outcomes compare total postprandial amino acid responses between P24 and placebo; secondary outcomes include essential and branched-chain amino acids, glucose, GLP-1, GIP, insulin, plasma peptide profiles, and subjective appetite and GI symptoms. Pre-test standardization limits confounding factors such as exercise, diet, and caffeine or alcohol use.

Why it matters

Potential benefit: If successful, P24 could help optimize amino acid availability after meals in healthy adults.

How similar studies have gone: Previous studies in enzyme supplementation have shown modest effects on digestion and amino acid responses, but this specific P24 postprandial profile in a crossover design is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Healthy adults aged 45-75 years
* BMI 18.5-35 kg/m2
* Able to provide informed consent and comply with study procedure
* Willing to consume the standardized mixed-protein test meal

Exclusion Criteria:

* BMI outside of 18.5-35 kg/m2
* Gastrointestinal disorders or malabsorption syndromes that could affect digestion/absorption (e.g., inflammatory bowel disease, celiac disease)
* Diagnosed diabetes
* Current use of medications or supplements that materially affect glucose metabolism or digestion (e.g., GLP-1 receptor agonists, chronic digestive enzyme supplementation)
* Resting blood pressure ≥ 140/90 mmHg
* Self-reported cancer within past 5 years
* Known allergy or intolerance to meal components or capsule ingredients
* Self-reported anemia or other conditions that increase risk from blood draws
* Pregnancy or breastfeeding
* Current smoking or nicotine use, heavy alcohol use (defined as \> 5 drinks/day or \> 15 drinks/week), or other factors that in the investigator's judgment make participation unsafe

Where it's running

  • Ragle Human Nutrition Center
    Davis, California, United States
    Recruiting

Study contacts

  • Principal investigator: Roberta H Holt, PhD — University of California, Davis
  • Study coordinator: Roberta Holt, PhD
  • Email: rrholt@ucdavis.edu
  • Phone: 530-400-5952

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.